We confirmed that the upregulation of p21 mRNA observed in the RNA-seq analysis corresponded to increased p21 protein expression in PGCC derived from PPC1 prostate cancer cells (Fig. 4A). The gene discussed is CDKN1A; the disease is prostate cancer.